← All organizations
Rowan University
Academic/HospitalWebsite ↗
Also known as: Cooper Health System | Cooper Hospital/University Medical Center | Cooper School of Medicine at Rowan University | Cooper University Health Care | Cooper University Health System | Cooper University Hospital | Cooper University Hospital, NJ | GSIDA | Qilu hospital, Shandong University | Rowan University | Rowan University School of Osteopathic Medicine | The Cooper Health System
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1996Last known activity
Jan 1, 2026
Timeline
1920s
- Jun 1, 1923
Rowan University— Founded
Drugs by trial phase (48 distinct, 34 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Adenocarcinoma
- Autism Spectrum Disorder
- Autistic Disorder
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cataract
- Disease
- Dyskinesias
- Epilepsia Partialis Continua
- Epilepsy
- Fatigue
- Fractures, Bone
- Fragile X Syndrome
- Heart Block
- Heart Failure, Systolic
- Infections
- Lung Neoplasms
- Mouth Neoplasms
- Neonatal Abstinence Syndrome
- Pancreatic Neoplasms
- Pancreatitis
- Parkinson Disease
- Parkinsonian Disorders
- Pemphigus
- Postoperative Nausea and Vomiting
- Purpura, Thrombocytopenic, Idiopathic
- Rib Fractures
- Sepsis
- Sick Sinus Syndrome
- Squamous Cell Carcinoma of Head and Neck
- Syncope
- Syndrome
- Thrombocytopenia
- Toxemia
- Vomiting
Recent trials (50)
- NCT07296120Sponsor investigatorPhase 4Jan 1, 2026
- NCT06636786OfficialPhase 2Oct 31, 2024
- NCT06636786CollaboratorPhase 2Oct 31, 2024
- NCT04188665Lead sponsorEarly Phase 1May 1, 2020
- NCT04245332Lead sponsorN/AJan 31, 2020
- NCT04141163Overall official - principal investigatorPhase 1/Phase 2Nov 30, 2019
- NCT04141163Reponsible party - principal investigatorPhase 1/Phase 2Nov 30, 2019
- NCT04141163Lead sponsorPhase 1/Phase 2Nov 30, 2019
- NCT03092011Overall official - principal investigatorPhase 4Mar 1, 2017
- NCT03092011Lead sponsorPhase 4Mar 1, 2017
- NCT03092011Reponsible party - principal investigatorPhase 4Mar 1, 2017
- NCT03034564Lead sponsorPhase 4Jan 1, 2017
- NCT03033199Overall official - principal investigatorPhase 2Jan 1, 2017
- NCT03013114Overall official - principal investigatorPhase 2Jan 1, 2017
- NCT03034564Overall official - principal investigatorPhase 4Jan 1, 2017
Details
- Founded
- Glassboro, NJ, US Jun 1, 1923
- Last known activity
- Jan 1, 2026